IMEZA PLUS (Imazethapyr 70% WG) is a selective, systemic herbicide specially designed for early post-emergence control of grassy and broadleaf weeds in soybean crops. Belonging to the imidazolinone chemical group, it offers powerful action through the inhibition of amino acid synthesis in weeds, resulting in their complete elimination. Its superior formulation ensures quick absorption, long-lasting control, and maximum crop safety.
| Active Ingredient | Imazethapyr 70% WG |
|---|---|
| Formulation Type | Water Dispersible Granule (WG) |
| Chemical Group | Imidazolinone |
| Mode of Action | Inhibits Acetohydroxy Acid Synthase (AHAS) enzyme, stopping amino acid production in weeds. |
| Recommended Crop | Soybean |
| Target Weeds | Grassy and Broadleaf Weeds |
| Application Timing | Early post-emergence (2–4 leaf stage of weeds) |
IMEZA PLUS is compatible with most insecticides and fungicides. However, always conduct a small jar test before mixing to ensure physical compatibility and avoid phytotoxicity.
Apply IMEZA PLUS using a knapsack sprayer equipped with a flat-fan nozzle for uniform spray coverage. Maintain adequate soil moisture and avoid drift to nearby crops.
| Crop | Dosage (per acre) | Application Stage |
|---|---|---|
| Soybean | As per label recommendation | Early post-emergence (2–4 leaf stage of weeds) |
Q1: What type of herbicide is IMEZA PLUS?
IMEZA PLUS is a selective systemic herbicide that targets grassy and broadleaf weeds in soybean.
Q2: When is the best time to apply IMEZA PLUS?
Apply during the early post-emergence stage when weeds are young and actively growing.
Q3: Is IMEZA PLUS safe for soybean crops?
Yes, it is crop-selective and safe when applied at the recommended dosage.
Q4: How does IMEZA PLUS control weeds?
It inhibits the AHAS enzyme in target weeds, stopping essential amino acid production, leading to weed death.
Disclaimer: The information above is intended for reference only. Always follow the directions and safety guidelines provided on the product label and leaflet.
No reviews yet.